Collection of Blood Samples for New Diagnostic Devices 2
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLumiraDx UK Limited
About this trial
To research and develop new state of the art diagnostic biomarkers on the LumiraDx Platform that are comparable to the approved gold standard reference methods and will radically enhance clinicians and patients ability to monitor health conditions and improve outcomes by delivering the results near patient at the point of care.
Eligibility criteria
Qualifiers
Subject 18 years of age.
Willing and able to provide written informed consent and comply with study procedures.
Patients attending a definitive care team with research capabilities which has been enroled in this collection study.
Patients who can read and understand written English.
Disqualifiers
Subject <18 years of age.
Vulnerable populations deemed inappropriate for the study by the sites Principal Investigator.
Patients who have previously been enroled in any LumiraDx NOVEL study in the past 3 months and re-entry would breach the 24mL and or 6 fingersitck maximums.
Trial design
Treatments tested in this trial
- Venous blood draw
- Fingerstick
Treatment groups
20,000 Participants
are divided into 1 treatment groupLocations
7University Hospital MonklandsML6 0JS, AirdrieScotland, United Kingdom
Royal Infirmary of EdinburghEH16 4SA, EdinburghScotland, United Kingdom
St John's HospitalEH54 6PP, EdinburghScotland, United Kingdom
Glasgow Royal InfirmaryG4 0SF, GlasgowScotland, United Kingdom
Sponsors and collaborators
LumiraDx UK Limited
Lead sponsor
Source ClinicalTrials.gov